Used to prevent blood clots in patients with acute coronary syndrome, ticagrelor works by inhibiting platelet aggregation. It reduces the risk of heart attack, stroke, and cardiovascular death when given alongside aspirin. Commonly prescribed after stent placement to keep arteries open, it offers faster onset and greater platelet inhibition compared to older antiplatelet drugs. Often used in both diabetic and non-diabetic patients with unstable heart conditions.